搜尋結果
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
Contents. Per tab Dihydrocodeine bitartrate 5 mg, guaifenesin 50 mg, DL-methylephedrine HCl 17.5 mg, chlorpheniramine maleate 1.5 mg. Per 100 mL syrup Dihydrocodeine bitartrate 50 mg, DL-methylephedrine HCl 131.25 mg, guaifenesin 375 mg, chlorpheniramine maleate 15 mg.
VWD paed patient <12 yr Prophylaxis 40-80 IU VWF:Ac/kg 1-3 times wkly. Haemophilia A population Minor bleeding episodes 10-15 IU/kg 12-24 hrly for 1-2 days (target peak FVIII 20-30%). Moderate to severe bleeding episodes eg, haemarthroses 15-40 IU/kg 8-24 hrly for 1-4 days (target peak FVIII 30-80%).
SC Primary hypercholesterolaemia & mixed dyslipidaemia (including HeFH) Adult & paed ≥10 yr 140 mg every 2 wk or 420 mg once mthly. HoFH Adult & paed ≥10 yr Initially 420 mg once mthly, can be up-titrated to 420 mg once every 2 wk if clinically meaningful response is not achieved after 12 wk. Patient on apheresis May initiate treatment w ...
Dosage/Direction for Use. Administered once daily, taken at the same time every day. Adult 1st wk: 5 mg/day; 2nd wk: 10 mg/day; 3rd wk: 15 mg/day; from 4th wk onwards: 20 mg/day. Max: 20 mg/day. Maintenance: 20 mg/day.
Unless otherwise prescribed the following dosages are recommended: ENDOXAN 200 mg/1 g, injection vials: For continuous treatment in adults and children 3 to 6 mg/kg body weight daily (equivalent to 120 to 240 mg/m 2 body surface). For intermittent treatment 10 to 15 mg/kg body weight (equivalent to 400 to 600 mg/m 2 body surface) at intervals ...
Dosage/Direction for Use. Initially 0.5 mg/kg daily for 4 wk. May be increased to 1 mg/kg daily. Patients who shows intolerance to initial dose: 0.1-0.2 mg/kg body wt daily.
